Lavidas Athanese

Avg. Two Year Performance

No purchase track record
39% Avg. Sale Return
18% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%(23%)(39%)3%39%
Sale Success Rate1 of 61 of 61 of 61 of 65 of 6

Ariad Pharmaceuticals Inc.

Drugs » Biotechnology

Director:

Holdings: 131.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--